Skip to main content

Table 4 Clinical outcomes of proximal femoral replacement implants

From: Survivorship and clinical outcomes of proximal femoral replacement in non-neoplastic primary and revision total hip arthroplasty: a systematic review

Author (year)

Preoperative (range)

Postoperative (range)

P (value)

Malkani et al. [17]

HHS 46±13 (31-83)

Mayo Clinic hip score 30±17 (11-60)

HHS 76±16 (41-94)

Mayo Clinic hip score 57±18 (18-75)

<0.01

<0.01

Haentjens et al. [18]

Merle d’Aubigné 5.1

Merle d’Aubigné 14.9

N/A

Parvizi et al. [3]

HHS 37.1 (15-61)

HHS 64.9 (13-91)

<0.05

Shih et al. [19]

HHS 30 (16.-42)

HHS 83 (68-92)

N/A

Schoenfeld et al. [20]

Primary: Merle d’Aubigné N/A

Revision: Merle d’Aubigné 3.77

Primary: Merle d’Aubigné 16

Revision: Merle d’Aubigné 12.5

N/A

Bertani et al. [21]

N/A

MSTS 13.8±6.8

N/A

Gebert et al. [22]

HHS 30 (8-63)

HHS 78 (57-95)

N/A

Sewell et al. [23]

HHS 28 (13-49)

TESS 26% (14-40)

HHS 69 (39-85)

TESS 71% (35-82)

<0.0001

<0.0001

Al Taki et al. [4]

WOMAC 49.2

OHS 34.9

SF-12 physical 30.8

SF-12 mental 38.9

UCLA activity 2.6

WOMAC 62.2

OHS 54.9

SF-12 physiscal 37

SF-12 mental 50.8

UCLA activity 3.9

0.168

0.003

0.220

0.030

0.528

McLean et al. [24]

N/A

SF-36 physical 53 (44-62)

SF-36 mental 51 (41-64)

TESS 68 (32-98)

N/A

Dean et al. [25]

N/A

HHS 71.4 (64-85)

N/A

Colman et al. [26]

N/A

N/A

N/A

Lundh et al. [27]

N/A

N/A

N/A

Grammatopoulos et al. [28]

N/A

OHS 28 (4-48)

N/A

Viste et al. [29]

HHS 42.8±20 (25.9-82.9)

HHS 65.8±15.6 (21-87.7)

0.0009

Fenelon et al. [30]

N/A

N/A

N/A

De Martino et al. [31]

N/A

N/A

N/A

Dieckmann et al. [32]

N/A

HHS 69 (40-94)

N/A

  1. MSTS Musculo-Skeletal Tumor Society score, TESS Toronto Extremity Salvage Score, HHS Harris Hip Score, N/A Not Available, OHS Oxford Hip Score, UCLA University of California at Los Angeles, WOMAC Western Ontario and McMaster Universities, N/A Not Available